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Purpose: To compare the global gene expression profile of stratified epithelia generated in vitro using simian virus 40
(SV40) immortalized human corneal epithelial cells with the previously reported gene expression of normal human corneal
epithelia.
Methods: Immortalized cells expanded in submerged culture were grown in an air-liquid interface of liquid permeable
collagen-coated filters to foster stratification and differentiation. Stratified epithelia displaying resistances exceeding 300
Ω · cm2 were dissolved in an RNA purification lysis buffer. Purified RNA was used to globally determine gene expression
levels using high-density single-channel oligonucleotide microarrays. Raw hybridization readings were converted into
relative gene expression levels using Robust Multi-array Average (RMA) algorithm. Expression levels for selected genes
were validated by real-time RT-qPCR. The biologic significance of the gene expression profiles was interpreted with the
help of several microarray software analysis tools and ad hoc thematical analysis.
Results: The stratified cell culture to native epithelial comparison identified over- and under-expression in 22% and 14%
of the probed genes, respectively. The larger expression decreases occurred in genes intimately associated with both the
stratified epithelial lineage at large such as keratin 14 and the corneal phenotype, such as keratin 12, connexin 43, aldehyde
dehydrogenases (ALDHs), and paired box gene 6 (PAX6) and its whole downstream transcriptome. Overexpression related
to genes associated with cell cycling stimulation.
Conclusions: The results indicate that the stratified corneal epithelial cell model generated using SV40 immortalized cells
may be useful only in certain research applications. Extrapolations of studies with these cells to actual tissue cells should
be done with a great deal of caution.
The corneal epithelium is a stratified lining that serves as
a critical protective barrier for the cornea. It prevents pathogen
infiltration  and  limits  fluid  inflow  into  the  transparent,
dehydrated  corneal  stroma.  The  latter  is  primarily
accomplished by high ionic resistance tight junctions coupled
to an apical membrane with low solute permeability [1]. The
junctions and the properties of the apical membrane develop
as upwardly migrating cells reach the most apical position in
a  constant  renewal  process  [2-5].  This  barrier  presents  a
challenge  for  the  intraocular  delivery  of  drugs  and  other
medically useful compounds through the trans-corneal route.
The stratified, compact nature of the lining also implies that
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applied  compounds  may  be  modified  or  metabolically
eliminated and thereby not reach their intended intra-corneal
or intra-ocular destinations.
In recent years, cell culture models based on both primary
and immortalized cells have been developed as potentially
reliable models of the native human corneal epithelium for
either basic research or chemical testing [6]. This latter aspect
reflect a need to find new means of ocular toxicity testing,
which currently rely on undesirable ex vivo or in vivo animal
experimentation (Draize test) [7]. A reliable in vitro human
cell model of the corneal epithelium would reduce the need
for such experiments and avoid the erroneous results that may
originate from species differences.
Continuously growing cells are preferred as an indefinite
source of human cells, because they are renewable and easily
maintained.  Simian  virus  40  (SV40)  immortalized  human
corneal  epithelial  (iHCE)  cell  lines  were  independently
developed by Araki-Sasaki et al. [8] and Kahn et al. [9].
Immortalization is elicited by the expression in the transduced
cells of the virus large T antigen, a master gene that causes
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2109global changes in gene expression [10]. These cells have been
widely  used  in  studies  aimed  at  characterizing  multiple
activities  or  features  of  the  corneal  epithelium,  including
wound  healing  [11-13],  gene  transfer  [14,15],  drug
transporters  [16-18],  cytotoxicity  [19,20],  and  penetration
properties of drugs [21].
In spite of the induced transformation, when grown on
permeable  filters  at  an  air-liquid  interface,  the  SV40
immortalized cells stratify, yielding multi-strata that resemble
in many aspects both epithelia generated with untransformed
corneal cells and native tissue [22]. Apical microvilli, tight
junctions,  and  desmosomes  can  be  easily  identified.  The
model epithelia possess substantial electrical resistances, and
their permeability to solutes approximates those of the native
epithelium over a wide range of physicochemical properties
[23]. Thus, tests with this model system may provide a viable
alternative to investigating ocular absorption and toxicity in
laboratory animals.
Yamasaki et al. [24] recently studied the genomic content
of this cell line. They found that the genome of these cells is
altered and contains several insertions and deletions compared
to the normal genome. Since cell immortalization with large
T antigen inhibits the function of tumor-suppressor proteins
p53 and retinoblastoma 1, which contribute to the repair of
DNA damage, genomic aberrations in the immortalized cells
having high passage numbers (over 60) were not unexpected.
Additionally,  they  investigated  gene  expression  by  the
expressed sequence tags (EST) method and identified over
700 dominantly transcribed genes in the immortalized cells.
A substantial fraction of genes encoding subunits of ribosomal
proteins suggested enhanced protein synthesis in this cell line.
Since gene expression is strongly affected by cell culture
conditions,  we  have  now  compared  the  gene  expression
profile of these cells when in the stratified, high transepithelial
resistance  condition,  which  is  used  to  mimic  the  normal
environment of the corneal epithelium, against the profile for
the  native,  freshly  isolated  epithelium  [22].  The  results
indicate  that  cells  in  the  iHCE-based  epithelium  exhibits
major  differences  in  gene  expression  with  respect  to  the
reference tissue, particularly in regard to components of the
tissue-specific phenotype.
METHODS
Cell  culture:  The  SV40  immortalized  human  corneal
epithelial  cell  line  (p4)  was  originally  obtained  from  Dr.
Hitoshi  Watanabe  (Osaka  University,  Osaka,  Japan)  [8].
During  the  cell  expansion  phase  the  iHCE  cells  were
maintained in DMEM/Ham’s F12 (1:1; Gibco, Invitrogen,
Paisley, UK), 15% FBS (Gibco, Invitrogen), 0.3 mg/ml L-
glutamine  (Gibco,  Invitrogen),  5  µg/ml  insulin  (Gibco,
Invitrogen), 0.1 µg/ml cholera toxin (Calbiochem, La Jolla,
CA),  10  ng/ml  EGF  (Invitrogen,  Carlsbad,  CA),  0.5%
dimethyl sulfoxide (DMSO; Sigma, St. Louis, MO), 0.1 mg/
ml  streptomycin,  and  1000  IU/ml  penicillin  (Gibco,
Invitrogen).  Cells  (passages  of  22–23)  were  seeded  on
collagen-coated permeable supports (Transwell® Polyester
Membrane Insert; Costar, Cambridge, MA) and cultured for
7  days  as  described  earlier  [22].  The  medium  was  then
supplemented with 40 µg/ml L(+)-ascorbic acid (Sigma, St.
Louis,  MO)  and  the  supra-apical  solution  was  removed.
Trans-epithelial electrical resistance was tracked in situ with
an  EVOM  resistance  meter  in  Endohm  chambers  (World
Precision Instruments, Sarasota, FL).
Microarray processing: Cultures with resistances exceeding
300 Ω · cm2 were dissolved in TriReagent (MRC, Columbus,
OH).  Total  RNA  isolated  from  this  solution  was  further
purified  using  RNAeasy  spin  columns  (Qiagen,  Valencia,
CA). RNA concentration and purity were determined from
260 nm and 280 nm absorbances. Integrity was determined
using the Agilent 2100 BioChip (Agilent Technologies., Palo
Alto, CA). The RNA was subjected to a single amplification
run, labeled with biotin nucleotides, digested into proper size
fragments, and hybridized to the HG-U133A gene microarray
(Affymetrix, Santa Clara, CA) following a standard protocol
established by Affymetrix. Hybridized chips were reacted
with FITC-avidin and raw fluorescence intensities were read
with a laser reader. HG-U133A contains >22,000 probes that
provide for the representation of about one-half of the human
genome.  The  raw  signal  intensity  readings  have  been
deposited in the Gene Expression Omnibus (GEO) under the
accession number GSE22539.
The tissue (t)HCE data used in this study were generated
previously for comparative study of gene expression profiles
in freshly isolated human corneal and conjunctival epithelia
[25]. The intact central cornea tHCE was obtained in that study
by overnight incubation of quarters of donor cadaver corneas
(procured from the National Disease Research Interchange
(Philadelphia, PA) at 4 °C in 5 μg/ml Dispase type II dissolved
in DMEM. The raw data in the form of an Affymetrix file can
be found in the public domain GEO, series accession number
GSE5543.
It is pertinent to point out that the experimental steps for
the generation of the microarray results, starting with RNA
repurification  and  ending  in  HG-U133A  signal  intensity
readings, were performed at the MicroaArray Shared Facility
of the Mount Sinai School of Medicine, New York, NY, under
near identical conditions, including reagent used, technical
personnel and automated microarray instrumentation.
Data analysis: Microarray raw data files for three independent
replicates of iHCE stratified cultures and previously published
tHCE generated from Dispase-isolated epithelia that were
processed in an identical manner to the current processing
were imported into R v. 2.8.0 Bioconductor [26]. Custom CDF
v. 10 was used to re-annotate the probes present on the HG-
U133A chipset according to the Entrez gene database [27].
This reannotation considers only the microarray probe most
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2110proximal to the 3′end of the target sequence. Relative gene
expression values were calculated by the Robust Multi-array
Average (RMA) algorithm. In this method, normalization is
performed across the whole data set; only the perfect match
(PM) of the Affymetrix probes are used [28]. iHCE/tHCE
ratios (Rs) are displayed throughout the tables as the logarithm
on the base 2 of R.
Differential  expression  was  tested  by  the  t-test
implemented in the limma package [29]. One set of over-, and
under-expressed genes consisted of those genes complying
with  the  p<0.01  criteria  after  application  of  the  post  hoc
Benjamini-Hochberg  correction,  which  allows  a  False
Discovery Rate (FDR) <1%. A second, highly restricted set
consisted of those genes complying with the p<0.01 filter after
processing the data using the exacting Bonferroni post hoc
correction.
The  Database  for  Annotation,  Visualization,  and
Integrated  Discovery  (DAVID)  functional  annotation  tool
[30] was used to identify over- and under-represented biologic
themes. Gene networks were inferred using the Genomatix
BiblioSphere v. 7.0 software. In the BiblioSphere process,
connections in the network were drawn if two genes were
either co-cited in the literature or contain consensus binding
sites in their promoter regions for specific transcription factors
and global differences in genes based on their promoters. In
addition,  differences  in  selected  critical  cell  signal
transduction  pathways  or  gene  families  were  manually
examined using pathways depicted in Kegg or Biocarta.
Real-Time  RT–PCR:  iHCE  RNA  was  isolated  from  two
separate  cell  culture  batches,  each  with  three  replicates,
distinct from those used for the microarray measurements.
Three independent replicates of tHCE samples were obtained
from  photorefractive  keratectomy  (PRK)  eye  surgery
performed at the Eye Clinic Silmäkeskus Laser Oy, Helsinki,
Finland. Collection of this tissue was sanctioned by the local
IRB and performed after obtaining informed, written consent
from the donors. The use of human tissues was in accordance
with the Declaration of Helsinki. Total RNA was isolated
from  these  samples  using  RNAqueous®  -Micro  or
RNAqueous®-4PCR kits (Ambion, Austin, TX).
Quantitative real-time RT–PCR was used to validate the
microarray results using a combination of over- and under-
expressed  genes.  Genomic  DNA  contamination  was
eliminated by treating the samples with DNase I (Ambion).
RNA  (2  µg)  was  transcribed  into  cDNA  using  M-MuLV
reverse transcriptase (Fermentas, Hanover, MD) and random
primers (Fermentas). The PCR reaction was conducted in an
ABI Prism 7000 instrument using TaqMan® Gene Expression
Master  Mix  (Applied  Biosystems,  Foster  City,  CA)
complemented with an amount of cDNA derived from 40 ng
RNA  and  Taqman®  Gene  Expression  Assays  (Applied
Biosystems; Table 1). For ABCB1 and ABCG2 genes, custom-
made primers and probes described in Korjamo et al. [31] were
used. Each sample was analyzed as triplicates and the relative
levels of expression were calculated by the comparative cycle
threshold  method  (ΔΔCT).  Normalization  was  performed
using the geometrical means of TAF1C (Hs00375863_m1)
and ABCB11 (Hs00184824_m1) CTs as normalizing values.
Commonly used normalization genes, ACTB and GAPDH,
have somewhat different expression levels in the iHCE and
tHCE and thus these genes were considered as unsuitable for
normalization.  TAF1C  and  ABCB11  genes  had  similar
expression levels in iHCE and tHCE based on both microarray
and real-time RT–PCR experiments. Therefore, these genes
were chosen for normalization. Statistical significance was
calculated using unpaired t-test.
TABLE 1. iHCE/ tHCE EXPRESSION RATIO (R) OF SELECTED GENES DETERMINED FOR MICROARRAYS (RMA METHOD) OR BY REAL-TIME PCR
Function Symbol Entrez gene
ID
Microarray Log2 R
(Adjusted p-value)
Real-time RT–PCR Log2
R (p-value)
TaqMan® gene
expression assay
Hair keratin KRT81 3887 5.04 (1.20E-05) 7.87 (3.16E-07) Hs00605559_m1
Hyaluronan-mediated motility
receptor
HMMR 3161 4.51 (1.39E-06) 4.11 (5.67E-07) Hs00234864_m1
Keratin of simple epithelia KRT7 3855 3.84 (1.79E-04) 10.07 (2.42E-09) Hs00818825_m1
Breast cancer resistance prot., stem
cell related
ABCG2 9429 2.60 (1.38E-05) 6.43 (1.44E-08) Custom-made*
MDR1; drug efflux pump ABCB1 5243 1.54 (1.73E-03) 8.63 (1.04E-07) Custom-made*
Protein phosphatase regulatory
subunit
SAPS3 55291 0.00 (9.93E-01) 1.09 (1.01E-03) Hs00217759_m1
Pore forming claudin CLDN15 24146 −0.53 (4.30E-03) 0.81 (2.08E-02) Hs00204982_m1
Receptor for hyaluronic acid CD44 960 −0.99 (8.85E-03) −0.43 (1.98E-01) Hs00153304_m1
MRP5; drug efflux pump ABCC5 10057 −1.37 (5.54E-04) −1.72 (2.17E-05) Hs00981071_m1
Component of tight junction strands CLDN1 9076 −3.43 (8.43E-04) −2.33 (1.31E-03) Hs01076359_m1
Marker for corneal epithelial
differentiation
KRT3 3850 −6.57 (1.23E-06) −20.27 (1.17E-11) Hs00365080_m1
Marker for corneal epithelial
differentiation
KRT12 3859 −8.60 (5.29E-08) −22.30 (1.34E-11) Hs00165015_m1
          The asterisk indicates described by Korjamo et al. [31].
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RNA and microarray quality tests and validation: High purity
and integrity of the iHCE RNA were comparable to those
obtained for the tHCE RNA [25]. The quality report produced
by AffyQCReport R Package [32] and hierarchical clustering
(Appendix 1) demonstrated that the microarray data were of
good quality and that the data from iHCE and tHCE formed
two separate groups. Overall, the microarray results correlated
well with the results of RT–PCR analysis in their direction
(Table  1).  The  PCR  measurement  consistently  yielded,
though, larger expression ratios than those reported by the
microarray. This is a common observation [33] likely due to
tendency of Affymetrix methodology to overestimate low
intensity reading (i.e., a noise issue).
Transcriptome differences: We took genes for which the p
values  in  Benjamini-Hochberg  corrected  iHCE-tHCE
comparisons were lower than 0.01 as differentially expressed.
This limit led to the definition of 2,630 and 1,685 genes as
over- or under-expressed in the iHCE, or 21.9% and 14% of
the total of 12,029 re-annotated genes. Because RMA does
not probe for the possibility that genes may be actually not
expressed in the tissue, as done in MAS5 analysis, e.g [25],
the  number  of  relevant  total  and  differential  genes  may
actually be smaller, but the percentiles involved are likely to
change only minimally.
Table 2 lists the number of differentially expressed genes
as a function of iHCE-tHCE expression ratio intervals. Table
3  summarizes  the  results  of  DAVID  analysis  for  the
differentially expressed genes. The complete lists of DAVID
functional annotation clustering of genes over- and under-
represented  in  iHCE  are  provided  in  Appendix  2  and
Appendix 3, respectively. The most over-represented gene
ontology categories were primarily associated with the cell
cycle, mitosis, and DNA metabolism. Under-representation
occurred  in  gene  categories  related  to  development,
differentiation, cell adhesion, and motility. Finally, Table 4
lists the most over- and under-expressed individual genes in
descending order of expression ratio. The complete lists of
differentially expressed genes by Benjamini-Hochberg and
Bonferroni post hoc corrections are provided in Appendix 4
and Appendix 5, respectively.
The stratified iHCE cell model was initially developed
for drug permeability studies. Expression of drug transporter
proteins  and  metabolizing  enzymes  determines  the
TABLE 2. NUMBER OF DIFFERENTIALLY EXPRESSED GENES REPRESENTED BY RATIO
  Number of genes (% of annotated genes)
Log2 R Over-expressed Under-expressed
≥ 4.0 75 (0.62) 87 (0.72)
3.0–3.99 107 (0.89) 89 (0.74)
2.0–2.99 339 (2.82) 161 (1.34)
1.5–1.99 426 (3.54) 202 (1.68)
TABLE 3. SELECTED OVER- AND UNDER-REPRESENTED GENE ONTOLOGY (GO) TERMS IN iHCE
Term Count p value
Over-represented
GO:0005634~nucleus 937 2.08E-52
GO:0007049~cell cycle 278 2.64E-46
GO:0044237~cellular metabolic process 1369 3.46E-39
GO:0006259~DNA metabolic process 241 5.66E-32
GO:0006396~RNA processing 149 5.51E-27
GO:0005739~mitochondrion 246 4.94E-25
GO:0005694~chromosome 130 1.69E-24
GO:0000166~nucleotide binding 437 2.88E-19
Under-represented
GO:0032502~developmental process 446 7.66E-26
GO:0007154~cell communication 500 1.01E-17
GO:0009653~anatomic struct. morph. 181 9.75E-16
GO:0007165~signal transduction 453 7.80E-15
GO:0030154~cell differentiation 254 3.78E-14
GO:0006928~cell motility 81 2.98E-11
GO:0031988~membrane-bound vesicle 68 3.06E-10
GO:0007155~cell adhesion 118 3.57E-09
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2112TABLE 4. TRANSCRIPTS WITH HIGHEST UNDER- AND OVEREXPRESSION IN THE iHCE.
Full Name Symbol
Entrez gene
ID Log2 R
Over-represented genes
ribonucleotide reductase M2 RRM2 6241 6.58
cyclin B1 CCNB1 891 5.58
maternal embryonic leucine zipper kinase MELK 9833 5.54
aurora kinase A AURKA 6790 5.53
discs, large (Drosophila) homolog-associated protein 5 DLGAP5 9787 5.38
GTP cyclohydrolase 1 GCH1 2643 5.34
Epithelial cell adhesion molecule EPCAM 4072 5.34
Dickkopf homolog 1 (X. laevis) DKK1 22943 5.25
cyclin-dependent kinase inhibitor 3 CDKN3 1033 5.12
topoisomerase (DNA) II alpha 170 kDa TOP2A 7153 5.10
keratin 81 KRT81 3887 5.04
neuropilin (NRP) and tolloid (TLL)-like 2 NETO2 81831 5.02
NDC80 homolog, kinetochore complex component (S. cerevisiae) NDC80 10403 5.02
centrosomal protein 55 kDa CEP55 55165 4.97
ZW10 interactor ZWINT 11130 4.94
interleukin 6 (interferon, beta 2) IL6 3569 4.94
Forkhead box A1 FOXA1 3169 4.92
cell division cycle 20 homolog (S. cerevisiae) CDC20 991 4.91
budding uninhibited by benzimidazoles 1 homolog beta (yeast) BUB1B 701 4.89
ELOVL family member 5, elongation of long chain fatty acids ELOVL5 60481 4.86
kinesin family member 23 KIF23 9493 4.82
meiosis-specific nuclear structural 1 MNS1 55329 4.81
geminin, DNA replication inhibitor GMNN 51053 4.78
RAD51 associated protein 1 RAD51AP1 10635 4.75
thymidylate synthetase TYMS 7298 4.74
kinesin family member 11 KIF11 3832 4.74
asp (abnormal spindle) homolog, microcephaly associated (Drosophila) ASPM 259266 4.72
annexin A3 ANXA3 306 4.71
sarcoglycan, epsilon SGCE 8910 4.69
epithelial cell transforming sequence 2 oncogene ECT2 1894 4.64
kinesin family member 15 KIF15 56992 4.64
myxovirus (influenza virus) resistance 1, interferon-inducible protein p78 MX1 4599 4.62
v-myb myeloblastosis viral oncogene homolog (avian)-like 1 MYBL1 4603 4.59
kinesin family member 20A KIF20A 10112 4.58
non-SMC condensin I complex, subunit G NCAPG 64151 4.56
activated leukocyte cell adhesion molecule ALCAM 214 4.55
hyaluronan-mediated motility receptor (RHAMM) HMMR 3161 4.51
ISG15 ubiquitin-like modifier ISG15 9636 4.50
nicotinamide N-methyltransferase NNMT 4837 4.45
bone marrow stromal cell antigen 2 BST2 684 4.44
Full Name Symbol
Entrez gene
ID
-Log2 R
Under-represented genes
keratin 14 KRT14 3861 8.93
aldehyde dehydrogenase 3 family, memberA1 ALDH3A1 218 8.72
keratin 12 KRT12 3859 8.60
gap junction protein, alpha 1, 43 kDa GJA1 2697 8.46
chemokine (C-X-C motif) ligand 14 CXCL14 9547 8.37
chromosome 10 open reading frame 116 C10orf116 10974 8.28
keratin 5 KRT5 3852 8.23
aldehyde dehydrogenase 1 family, member A1 ALDH1A1 216 7.97
clusterin CLU 1191 7.59
S100 calcium binding protein A4 S100A4 6275 7.47
keratin 24 KRT24 192666 7.46
desmoglein 1 DSG1 1828 7.29
cartilage acidic protein 1 CRTAC1 55118 6.88
mal, T-cell differentiation protein MAL 4118 6.79
tripartite motif-containing 29 TRIM29 23650 6.71
paired box 6 PAX6 5080 6.60
keratin 3 KRT3 3850 6.57
chloride channel accessory 2 CLCA2 9635 6.23
HOP homeobox HOPX 84525 6.17
desmocollin 3 DSC3 1825 5.99
crystallin, alpha B CRYAB 1410 5.92
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were  examined  more  closely,  and  the  over-  and  under-
expressed genes are listed in Table 5. Both the under- and
overexpressed gene lists include members from the same gene
families, suggesting that expression must be investigated at
the level of individual genes. The full data set is found in
Appendix 4.
Cell fate genes: Transcription factors and other genes acting
as master genes for cell fate determine the overall pattern of
gene  expression  of  a  cell.  Thus,  to  identify  the  potential
regulatory roots of the large expression differences between
iHCE and tHCE, the subset of differentially expressed genes
that complied with p<0.01 after applying the very exacting
Bonferroni post hoc correction was used to develop gene-gene
proximity maps with BiblioSphere. The Bonferroni compliant
set  consisted  of  478  genes,  317  of  which  were  under-
expressed.  Paired  box  gene  6  (PAX6)  emerged  from  this
analysis as the central gene, with possible binding sites on the
promoters of several other genes in the tHCE (Figure 1). More
detailed analysis of these promoters revealed a conserved
module that is constituted by the consensus binding sites for
PAX6 and BRN5 transcription factor families (Figure 2).
DISCUSSION
Reliable in vitro cell models are needed to mimic the human
corneal epithelium. Such models should have a phenotype that
maximally resembles the normal corneal epithelium. DNA
microarrays enable a holistic analysis of gene expression, thus
providing a powerful tool for comparing mortal, native tissue
cells with transformed or immortalized cells which have been
intentionally or spontaneously derived from the former and
which may facilitate or accelerate research in the mother organ
or tissue. The SV40 immortalized HCE cell line is widely used
in ophthalmology.
In the present report, we have studied the gene expression
in a stratified epithelium generated with the same cell line, but
the cells were cultured on the semipermeable collagen coated
membrane  under  airlift  conditions  to  mimic  the  normal
environment  in  the  cornea.  The  original  22,000  plus
Affymetrix reads of the HG-U133A chip were re-annotated
using a sequence-based that has been shown to improve on
the  annotations  provided  by  the  microarray  manufacture
[27]. We have successfully used this approach in previous
studies [34-36]. The robust computational methods applied
revealed  significant  differences  between  the  expression
profiles  of  the  transformed  and  parent  human  corneal
epithelia.  Upwards  of  36%  of  the  listed  genes  fitted  the
adopted  definition  for  differential  expression.  Highly
expressed  corneal  epithelial  genes  were  related  to  the
fundamental  developmental  processes.  Cell-cell
communication,  cell  adhesion,  and  differentiation  were
drastically  repressed  by  the  SV40  transformation  process.
Simultaneously, the expression of genes critically engaged in
the control of cell division, in particular those associated with
the  G2/M  progression  and  mitosis,  underwent  dramatic
enhancements.
The  changes  in  keratin  expression  profiles  provide  a
robust,  patent  example  of  the  large  gene  perturbation  in
terminal  differentiation  associated  with  the  SV40  large  T
antigen effects [10]. Each stratified epithelium is defined by
a distinct intermediate filament expression profile, and the
corneal lining is characterized by the expression of its own
keratin pair, keratin 3 (KRT3), and keratin 12 (KRT12) [37].
Respective to the in vivo expression of these two keratins, in
the stratified SV40 cells expression was reduced by at least a
hundredfold (Table 4). Previous studies have identified other
genes undergoing similar changes in parallel to keratin, in
particular connexin 43 and aldehyde dehydrogenase (ALDH)
[38]. The strong de-expression of these two latter genes is a
TABLE 4. CONTINUED.
Full Name Symbol
Entrez gene
ID -Log2 R
chloride channel accessory 4 CLCA4 22802 5.61
insulin-like growth factor binding protein 2, 36 kDa IGFBP2 3485 5.61
secretoglobin, family 2A, member 1 SCGB2A1 4246 5.58
collagen, type XVII, alpha 1 COL17A1 1308 5.47
hepatic leukemia factor HLF 3131 5.38
tripartite motif-containing 36 TRIM36 55521 5.36
keratin 15 KRT15 3866 5.32
keratin 4 KRT4 3851 5.32
v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog KIT 3815 5.09
cadherin 13, H-cadherin (heart) CDH13 1012 5.08
calmodulin-like 3 CALML3 810 5.04
mal, T-cell differentiation protein-like MALL 7851 5.04
uroplakin 1B UPK1B 7348 5.01
PERP, TP53 apoptosis effector PERP 64065 4.97
serpin peptidase inhibitor, clade F, member 1 SERPINF1 5176 4.96
lysophosphatidic acid receptor 6 LPAR6 10161 4.96
visinin-like 1 VSNL1 7447 4.87
LY6/PLAUR domain containing 3 LYPD3 27076 4,83
zinc finger, BED-type containing 2 ZBED2 79413 4.80
Molecular Vision 2010; 16:2109-2120 <http://www.molvis.org/molvis/v16/a226> © 2010 Molecular Vision
2114further confirmation of the immortalization process on tissue
specific  differentiation  events  (Table  4).  The  effects  on
phenotype, though, were not limited to those associated with
the differentiated state. Multiple keratins associated with the
undifferentiated state of stratified epithelial and even with
their stem cells including KRT4, KRT5,KRT14, and KRT15
[39] also underwent major reduction in expression following
transformation while keratins of the simple epithelial cells
(KRT7 and KRT18) [39] became overexpressed. In summary,
these  results  suggest  that  iHCE  cells  are  ingrained  with
disturbances in their differentiation plan.
Mechanisms of gene regulation can be inferred from large
gene expression studies by assuming that co-expressed or co-
regulated genes might also be under the control of the same
transcription factors [36]. The PAX6 gene acts as the central
master gene of eye morphogenesis. It is expressed in the
corneal epithelium through development and adulthood. Its
dosage is a critical determinant of migration, differentiation,
and limbal stem cell function, where it determines critical
behavior of the limbal-corneal stem cells [40-45]. Hence, the
inadequate differentiation indicated by the keratin expression
disturbance may originate in the absence of PAX6 expression
in iHCE cells. Interestingly, our analysis reveals that BRN5
might act as a co-regulator of PAX6 in the corneal epithelium.
One of the main drivers for the development of iHCE
lines was the need to establish in vitro models for corneal drug
permeation studies [22]. The corneal epithelium is the main
barrier  that  limits  the  absorption  of  topically  applied
ophthalmic drugs [46]. Stratified iHCE culture and ex vivo
rabbit cornea showed similar paracellular space and passive
permeability  of  26  hydrophilic  and  lipophilic  compounds
[23].  The  results  of  this  study  (Table  5)  show  dissimilar
TABLE 5. DRUG TRANSPORTERS AND METABOLIZING ENZYMES.
Full name Symbol Entrez Gene
ID
Log2 R
Over-represented genes in iHCE
Solute carrier F. 2 (facilitated glucose transporter), M. 10 SLC2A10 81031 3.81
Solute carrier F. 7 (cationic amino acid transporter, y+ system), M. 5 SLC7A5 8140 3.61
Solute carrier F. 22 (organic cation/ergothioneine transporter), M. 4 SLC22A4 6583 3.00
ATP-binding cassette, sub-F. G (WHITE), M. 2 ABCG2 9429 2.60
Transporter 1, ATP-binding cassette, sub-F. B (MDR/TAP) TAP1 6890 2.08
Cytochrome P450, F. 1, sub-F B, polypeptide 1 CYP1B1 1545 1.88
ATP-binding cassette, sub-F. B (MDR/TAP), M. 7 ABCB7 22 1.83
ATP-binding cassette, sub-F. C (CFTR/MRP), M. 4 ABCC4 10257 1.67
ATP-binding cassette, sub-F. C (CFTR/MRP), M. 3 ABCC3 8714 1.56
ATP-binding cassette, sub-F. B (MDR/TAP), M. 1 ABCB1 5243 1.54
Solute carrier F. 1 (glial high affinity glutamate transporter), M. 3 SLC1A3 6507 1.52
Solute carrier F. 16, M. One (monocarboxylic acid transporter 1) SLC16A1 6566 1.40
Solute carrier F. 2 (facilitated glucose transporter), M. 3 SLC2A3 6515 1.32
Solute carrier F. 15, M. 3 SLC15A3 51296 1.19
Solute carrier F. 2 (facilitated glucose transporter), M. 6 SLC2A6 11182 0.89
Solute carrier F. 2 (facilitated glucose transporter), M. 8 SLC2A8 29988 0.80
Full name Symbol Entrez Gene
ID
-Log2 R
Under-represented genes in iHCE
Solute carrier F. 7 (cationic amino acid transporter, y+ system), M. 8 SLC7A8 23428 3.24
Solute carrier F. 2 (facilitated glucose transporter), M. 1 SLC2A1 6513 2.16
Solute carrier F. 22, M. 14 SLC22A14 9389 1.68
Solute carrier F. 2 (facilitated glucose/fructose transporter), M. 5 SLC2A5 6518 1.67
ATP-binding cassette, sub-F. B (MDR/TAP), M. 6 ABCB6 10058 1.38
ATP-binding cassette, sub-F. C (CFTR/MRP), M. 5 ABCC5 10057 1.37
ATP-binding cassette, sub-F. G (WHITE), M. 1 ABCG1 9619 1.29
Cytochrome P450, family 2, sub-F. C, polypeptide 18 CYP2C18 1562 1.26
ATP-binding cassette, sub-F. C (CFTR/MRP), M. 8 ABCC8 6833 1.15
Cytochrome P450, family 2, sub-F. C, polypeptide 19 CYP2C19 1557 1.01
Solute carrier F. 2 (facilitated glucose transporter), M. 9 SLC2A9 56606 1.01
Solute carrier F. 22, M. 17 SLC22A17 51310 0.99
Solute carrier F. 6 (proline IMINO transporter), M. 20 SLC6A20 54716 0.83
Cystic fibrosis transmemb. conductance regulator (ABC sub-F. C, M. 7) CFTR 1080 0.73
Cytochrome P450, family 2, sub-F. C, polypeptide 9 CYP2C9 1559 0.70
Solute carrier F. 5 (sodium/glucose cotransporter), M. 1 SLC5A1 6523 0.66
Cytochrome P450, F. 1, sub-F. A, polypeptide 2 CYP1A2 1544 0.66
Solute carrier F. 22 (organic anion/urate transporter), M. 11 SLC22A11 55867 0.61
Solute carrier F. 6 (neurotransmitter transporter, betaine/GABA), M. 12 SLC6A12 6539 0.57
Solute carrier F. 7 (cationic amino acid transporter, y+ system), M. 4 SLC7A4 6545 0.52
Solute carrier F. 16, M. Four (monocarboxylic acid transporter 5) SLC16A4 9122 0.49
         In the table, F indicates family and M indicates member.
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2115expression of membrane transporters and metabolic enzymes
in the cell model and human corneal epithelium, respectively.
This is in line with the recently published differences in the
expression and functionality of monocarboxylate transporters
[18] and ABC class efflux transporters [17] in the human
corneal epithelium and cultured iHCE model. We should note,
however, that the roles of membrane transporters and enzymes
in ocular drug absorption are poorly understood.
Our recent literature analysis [47] revealed that 39 ocular
drugs are known to be substrates to membrane transporters,
but information about the expression and functionality of the
transporters in the cornea is still sparse. Therefore, the impact
of membrane transporters in the corneal drug absorption is
Figure 1. Network of the upregulated genes in the normal corneal epithelial tissue (p<0.01) after Bonferroni correction. Each box represents
a gene; black edges represent co-citation and green edges indicate the binding of specific transcription factor on the gene promoter.
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2116unknown.  Even  though  the  DNA  array  analysis  reveals
differences in the transporter and enzyme expressions in the
iHCE model and normal corneal epithelium (Table 5), there
are no clear trends related to the families of transporters or
enzymes. For example, both ABC and SLC transporters are
found in the lists of overexpressed and under-expressed genes.
Expression and functionality of transporter proteins should be
further investigated and scaled to tissue properties before a
stratified cell system based on the iHCE approach can be
reliably  applied  to  studies  of  active  drug  transport  and
metabolism.
The iHCE divergency in gene expression, though, may
not occur or be so marked for features not associated with
differentiation. Polarization and tightness of cell layers is a
landmark  of  epithelial  cell  differentiation.  The  iHCE  cell
forms  a  tight  permeation  barrier  with  tight  junctions  and
desmosomes shown at electron microscope level [22]. In this
study, barrier properties of the cell model were confirmed by
measuring transepithelial electrical resistance. Claudins 1, 4,
and 11, which have been linked to the electric resistance and
tightness of the cell barriers [48], were expressed at higher
levels in the corneal epithelium than in the iHCE, but overall
the expression differences for tight junction proteins were
substantially less pronounced than those of the phenotype-
associated  markers,  as  were  the  genes  coding  for  the
desmosomal and cell-cell adhesion proteins desmoglein 1,
desmoglein 3, desmocollin 3, and cadherin 13 [49] (Appendix
4). Finally, using the same microarray data analyzed in this
report, Wang et al. [50] recently demonstrated a remarkable
similarity of expression levels for most of the typical dual
specificity phosphatases.
Figure 2. Network of the upregulated cornea-specific genes in the normal corneal epithelial tissue (p<0.01) after Bonferroni correction. Each
box represents a gene; black edges represent co-citation and green edges indicate the presence of transcription factor binding of specific
transcription factor on the promoter of the regulated gene.
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2117In conclusion, we demonstrated the differences in the
global gene expression between the human corneal epithelium
and stratified filter cultured cell culture system. Despite the
correct  morphology  and  barrier  formation,  there  are  still
significant deviations of expression from the normal corneal
epithelium. The SV40 transformed corneal epithelial cells
could provide a useful model for certain areas of biologic
study. However, the validity of the studies using these cells
should be reconfirmed by parallel studies using native tissue
or primary cells.
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hierarchical clustering of iHCE and tHCE data.
To access the data, click or select the words “Appendix
1.” This will initiate the download of a compressed (pdf)
archive that contains the file.
Appendix 2. Functional annotation clustering of genes over-represented in
iHCE.
To access the data, click or select the words “Appendix
2.” This will initiate the download of an Excel archive that
contains the file.
Appendix 3. Functional annotation clustering of genes under-represented
in iHCE.
To access the data, click or select the words “Appendix
3.” This will initiate the download of an Excel archive that
contains the file.
Appendix  4.  Differentially  expressed  genes  by  Benjamini-Hochberg
correction.
To access the data, click or select the words “Appendix
4.” This will initiate the download of an Excel archive that
contains the file.
Appendix  5.  Differentially  expressed  genes  by  Bonferroni  post  hoc
correction.
To access the data, click or select the words “Appendix
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